Peter Brams
60Patents
17h-index
71Co-inventors
87Inventor score
Filing activity: Jul 22, 1991 → Jul 28, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5811524A | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof | Chemistry; Metallurgy | 107 | Expired |
| US7910798B2 | Transgenic animals expressing chimeric antibodies for use in preparing human antibodies | Chemistry; Metallurgy | 106 | Active |
| US6113898A | Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies | Human Necessities | 106 | Expired |
| US5958765A | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof | Chemistry; Metallurgy | 79 | Expired |
| US7960515B2 | Binding molecules to the human OX40 receptor | Chemistry; Metallurgy | 67 | Active |
| US7217796B2 | Neutralizing human anti-IGFR antibody | Chemistry; Metallurgy | 60 | Expired |
| US5939068A | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof | Chemistry; Metallurgy | 54 | Expired |
| US5866125A | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof | Chemistry; Metallurgy | 53 | Expired |
| US5840298A | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof | Chemistry; Metallurgy | 49 | Expired |
| US5955364A | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof | Chemistry; Metallurgy | 45 | Expired |
| US6537809B2 | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof | Chemistry; Metallurgy | 41 | Expired |
| US6413771B1 | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof | Chemistry; Metallurgy | 34 | Expired |
| US8236930B2 | Binding molecules to the human OX40 receptor | Chemistry; Metallurgy | 31 | Active |
| US9028824B2 | Binding molecules to the human OX40 receptor | Chemistry; Metallurgy | 26 | Active |
| US9683998B2 | Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof | Chemistry; Metallurgy | 21 | Active |
| US6893638B2 | Methods for treating b cell lymphoma using CD80-specific antibodies | Human Necessities | 18 | Expired |
| US5259749A | Apparatus for feeding synthetic resin material to injection molding and extruder units | Emerging Cross-Sectional Technologies | 17 | Expired |
| US8232449B2 | Transgenic animals expressing chimeric antibodies for use in preparing human antibodies | Chemistry; Metallurgy | 15 | Active |
| US6709654B1 | Treatment of psoriasis using anti-B7.1 (CD80) antibodies | Human Necessities | 15 | Expired |
| US8383118B2 | Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 | Chemistry; Metallurgy | 10 | Active |
| US7947807B2 | Method for obtaining G protein-coupled receptor (GPCR) diffraction-quality crystals employing a monoclonal antibody that binds to the third intracellular loop (IL3) | Chemistry; Metallurgy | 10 | Active |
| US9631025B2 | Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 antibodies | Chemistry; Metallurgy | 9 | Active |
| US9138475B2 | Human monoclonal antibodies to Fucosyl-GM1 and methods for using anti-Fucosyl-GM1 antibodies | Chemistry; Metallurgy | 9 | Active |
| US5858422A | Pressure and alignment compensator for a press | Performing Operations; Transporting | 8 | Expired |
| US7192585B2 | CD80 specific antibodies | Chemistry; Metallurgy | 8 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.